- Home
- XPRO vs TLRY Comparison
XPRO vs TLRY Comparison
Compare XPRO & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XPRO | TLRY |
|---|---|---|
| Founded | 1938 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | XPRO | TLRY |
|---|---|---|
| Price | $12.92 | $11.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $14.00 | ★ $150.00 |
| AVG Volume (30 Days) | 1.0M | ★ 18.2M |
| Earning Date | 10-23-2025 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 313.92 | N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $1,661,811,000.00 | $830,766,000.00 |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | $1.78 | $4.51 |
| P/E Ratio | $21.06 | ★ N/A |
| Revenue Growth | N/A | ★ 2.31 |
| 52 Week Low | $6.70 | $3.51 |
| 52 Week High | $15.04 | $23.20 |
Technical Indicators
Market Signals| Indicator | XPRO | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 41.79 | 68.14 |
| Support Level | $12.49 | $10.50 |
| Resistance Level | $14.91 | $15.70 |
| Average True Range (ATR) | 0.52 | 1.49 |
| MACD | -0.24 | 0.46 |
| Stochastic Oscillator | 18.46 | 47.67 |
Price Performance
Historical ComparisonAbout XPRO Expro Group Holdings N.V.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.